Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports.
Background: Adverse drug reaction (ADR) is a major burden for patients and healthcare industry. Early and accurate detection of potential ADRs can help to improve drug safety and reduce financial costs. Post-market spontaneous reports of ADRs remain a cornerstone of pharmacovigilance and a series of...
| Published in: | BMC Medical Informatics & Decision Making Vol. 19; no. 1; pp. 1 - 10 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Published: |
BioMed Central
12/18/2019
|
| Online Access: | View this record in EBSCOhost |